Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)
Authors
Keywords
-
Journal
HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-14
DOI
10.1002/hep.30561
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients
- (2018) Edoardo G. Giannini et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis
- (2018) Lorenzo Loffredo et al. DIGESTIVE AND LIVER DISEASE
- Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
- (2018) Norah Terrault et al. GASTROENTEROLOGY
- A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
- (2018) Ryosuke Tateishi et al. JOURNAL OF GASTROENTEROLOGY
- Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis
- (2018) Filippo Schepis et al. SEMINARS IN LIVER DISEASE
- Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference
- (2018) C. K. Argo et al. THROMBOSIS AND HAEMOSTASIS
- Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
- (2018) Hisashi Hidaka et al. Clinical Gastroenterology and Hepatology
- Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia
- (2017) Grazia Napolitano et al. European Journal of Internal Medicine
- Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects
- (2016) Takayuki Katsube et al. CLINICAL PHARMACOKINETICS
- Thrombocytopenia in chronic liver disease
- (2016) Markus Peck-Radosavljevic LIVER INTERNATIONAL
- Lusutrombopag: First Global Approval
- (2015) Esther S. Kim DRUGS
- Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy
- (2013) Nezam H. Afdhal et al. GASTROENTEROLOGY
- Platelet Transfusion Improves Liver Function in Patients with Chronic Liver Disease and Cirrhosis
- (2013) Takehito Maruyama et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
- (2012) Nezam H. Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease
- (2010) Edoardo G. Giannini et al. Clinical Gastroenterology and Hepatology
- Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
- (2010) Leonard B. Seeff et al. Clinical Gastroenterology and Hepatology
- A Prospective Study of Conventional and Expanded Coagulation Indices in Predicting Ulcer Bleeding After Variceal Band Ligation
- (2009) Evandra Cristina Vieira da Rocha et al. Clinical Gastroenterology and Hepatology
- Thrombocytopenia associated with chronic liver disease
- (2008) Nezam Afdhal et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More